Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Rockefeller University 

1230 York Avenue

New York  New York    U.S.A.
Phone: 212-327-8000 Fax:



Functional Genetics, Inc.  Discovering new gene-based targets for the treatment of Alzheimer's disease with Dr. Paul Greengard and his research team at the Rockefeller University.

Astralis, Ltd.  Dr. James Krueger, Head of Laboratory for Investigative Dermatology and Associate Professor at Rockefeller University, New York, New York, Evaluation of Psoraxine's(tm) Mechanism of Action

Argos Therapeutics, Inc.  Exclusive worldwide rights to technology developed at Rockefeller relating to generation of dendritic cells.

 Company News
A Single Gene May Decide Why Some People Get So Sick With The Flu, Rockefeller University Study 3/27/2015 6:59:23 AM
Why Mosquitoes Love The Human Scent, Rockefeller University Reveals 11/13/2014 6:53:33 AM
Agilis Biotherapeutics Appoints Dr. James E. Darnell, Jr. Of Rockefeller University To Scientific Advisory Board 9/30/2014 9:57:52 AM
NeoStem, Inc. Announces Licensing Of Patent Portfolio From The Rockefeller University Expanding Its Cancer Immunotherapy Intellectual Property Portfolio 9/11/2014 7:53:37 AM
Drug Could Stop Alzheimer's By Targeting Clotting Protein, Rockefeller University Study 6/30/2014 7:27:15 AM
New AIDS Monkey Model Offers Promise For Medical Research, Rockefeller University Study 6/23/2014 6:24:03 AM
New RNA Interference Technique Finds Seven Genes For Head And Neck Cancer, Rockefeller University Study 2/17/2014 6:28:03 AM
Rockefeller University Bestowed With $25 Million For Drug Discovery 1/24/2014 6:47:24 AM
Gene is Linked to Deadly Runaway Fungal Infection, Rockefeller University and Necker Medical School Study 11/6/2013 6:46:18 AM
Tri-Institutional Therapeutics Discovery Institute, Inc. Launched by Memorial Sloan-Kettering Cancer Center, the Rockefeller University and Weill Cornell Medical College, and Partnership Formed With Takeda Pharmaceutical Co. Ltd. (TKPYY) 10/1/2013 10:00:11 AM